LAS VEGAS, March 12 /PRNewswire-FirstCall/ -- PhytoLabs Inc., (formerly Jurak Corporation World Wide Inc. ) is pleased to announce that the company has completed a name change that has been approved and the new trading symbol is “PYTL” effective March 13, 2007.
The company’s wholly-owned subsidiary, PhytoLab Solutions Inc.'s initial product is a new, patent-pending extract for which they were granted world-wide distribution rights by the Danish life science company Nordic Immotech Trading ApS. Developed by leading research scientists at the National Center for Natural Products Research (NCNPR) at the University of Mississippi, the new, patent-pending extract " ... is one of the most promising projects our Center has produced in recent years, including its intellectual property,” says Dr. Walter G. Chambliss, Director of Technology Management at the University of Mississippi.
The NCNPR is the only university-affiliated research center in the United States devoted to improving human health and agricultural productivity through the discovery, development, and commercialization of pharmaceuticals and agrochemicals derived from natural products. The Center has a cooperative agreement with the Food and Drug Administration (FDA) to help assess the safety of botanical dietary supplements.
PhytoLab Solutions Inc. is a life science company focused on the global commercialization of unique, patented and scientifically proven self-medication health products and is currently working on packaging and branding this first product to make its broad immuno-stimulatory benefits widely available to North American consumers. The company is simultaneously working on developing partnerships to open European markets some of which are in the advanced stages.
The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products or actions in development are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company’s actual results may differ materially from expected results.
PhytoLabs Inc.
CONTACT: Anthony Jurak of PhytoLabs Inc., +1-702-498-6409
